Adjuvant treatment of postmenopausal women w/ hormone receptor +ve early breast cancer; extended adjuvant treatment of early breast cancer in postmenopausal women who have received prior standard adjuvant tamoxifen therapy for 5 yr. 1st-line treatment in postmenopausal women w/ hormone-dependent advanced breast cancer. Advanced breast cancer in women w/ natural or artificially induced postmenopausal status after relapse or disease progression, who have previously been treated w/ anti-oestrogens.
Sign Out
